Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin in Platinum Sensitive Ovarian Cancer
NCT04457089Phase 1Completed
- Start
- Jan 2021
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of simvastatin in ovarian cancer. Primary endpoint: Completion of the simvastatin intervention with at least 85% compliance at 6 months. Started Jan 2021; status: completed.
02
Drugs
simvastatin
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT04457089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04457089.